| scholarly article | Q13442814 |
| P2093 | author name string | Gary S Wood | |
| Katrin Agnes Salva | |||
| P2860 | cites work | Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma | Q44779579 |
| Long-term follow-up of photodynamic therapy for mycosis fungoides | Q46595183 | ||
| Selective action of the photosensitizer QLT0074 on activated human T lymphocytes. | Q50498827 | ||
| Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides. | Q50520650 | ||
| Selective destruction of leukaemic cells by photo-activation of 5-aminolaevulinic acid-induced protoporphyrin-IX | Q63686721 | ||
| Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells | Q68032753 | ||
| Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid | Q72197019 | ||
| Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells | Q73307502 | ||
| Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells | Q73836138 | ||
| Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression | Q80806681 | ||
| Current evidence and applications of photodynamic therapy in dermatology | Q26822964 | ||
| Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model. | Q30816583 | ||
| Photodynamic therapy: unapproved uses, dosages, or indications | Q34999579 | ||
| c-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death | Q35071772 | ||
| Quantitative gene analysis of methylation and expression (Q-GAME) in fresh or fixed cells and tissues | Q35124821 | ||
| Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy | Q35390981 | ||
| Regulation of T-cell apoptosis by reactive oxygen species. | Q35795618 | ||
| How does photodynamic therapy work? | Q36204382 | ||
| Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis | Q36502053 | ||
| Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells | Q36612248 | ||
| Current status of photodynamic therapy in dermatology | Q36866329 | ||
| Caspase-8 and bid: caught in the act between death receptors and mitochondria | Q37835913 | ||
| Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL) | Q38339708 | ||
| Photodynamic therapy (PDT) - Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines | Q39485230 | ||
| Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma | Q39617721 | ||
| 5-aminolevulinic acid induce apoptosis via NF-κB/JNK pathway in human oral cancer Ca9-22 cells | Q39622922 | ||
| Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo | Q39850358 | ||
| Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation | Q39928789 | ||
| Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma | Q39938055 | ||
| Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4. | Q40020538 | ||
| The effect of psoralen plus ultraviolet A in vitro in HUT-78 enhances by 5-aminolevulinic acid | Q40128294 | ||
| Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells | Q40134083 | ||
| Apoptosis signalling mechanisms in human cancer cells induced by Calphostin-PDT. | Q40175649 | ||
| Massive apoptotic cell death of human glioma cells via a mitochondrial pathway following 5-aminolevulinic acid-mediated photodynamic therapy | Q40179755 | ||
| Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells | Q40221001 | ||
| Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines | Q40278287 | ||
| Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest | Q40390409 | ||
| Photodynamic therapy with 5-aminolevulinic acid induces apoptosis and caspase activation in malignant T cells | Q40815810 | ||
| Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndrome | Q41234153 | ||
| The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species | Q41978298 | ||
| Photodynamic therapy induced Fas-mediated apoptosis in human carcinoma cells | Q42166867 | ||
| Sequential systemic retinoid and photodynamic therapy for multiple keratotic pigmented nodular basal cell carcinomas on the scalp | Q42459105 | ||
| Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience | Q42478415 | ||
| Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event | Q42550983 | ||
| Plaque-phase mycosis fungoides treated with photodynamic therapy: results from 12 patients | Q42842365 | ||
| The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis | Q43736417 | ||
| Fas ligand and TRAIL augment the effect of photodynamic therapy on the induction of apoptosis in JURKAT cells | Q43741068 | ||
| Topical photodynamic therapy with 5-aminolevulinate for the treatment of tumor-stage mycosis fungoides: a case report | Q44394092 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1444-1451 | |
| P577 | publication date | 2015-08-25 | |
| P1433 | published in | Photochemistry and Photobiology | Q3381560 |
| P1476 | title | Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T-Cell Lymphoma | |
| P478 | volume | 91 |
| Q26740306 | An overview of cutaneous T cell lymphomas |
| Q52575394 | Epigenetically Enhanced PDT (ePDT) Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT, Resulting in Greater Extrinsic and Overall Apoptosis of CTCL. |
| Q98726595 | Photodynamic therapy regulates fate of cancer stem cells through reactive oxygen species |
| Q59794233 | Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma |
| Q35071772 | c-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death |
Search more.